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ABSTRACT
TagI belongs to the recently characterized SRA-
HNH family of modification-dependent restriction en-
donucleases (REases) that also includes ScoA3IV
(Sco5333) and TbiR51I (Tbis1). Here, we present a
crystal structure of dimeric TagI, which exhibits a
DNA binding site formed jointly by the nuclease
domains, and separate binding sites for modified
DNA bases in the two protomers. The nuclease do-
mains have characteristic features of HNH/-Me
REases, and catalyze nicks or double strand breaks,
with preference for /RY and RYN/RY sites, respec-
tively. The SRA domains have the canonical fold.
Their pockets for the flipped bases are spacious
enough to accommodate 5-methylcytosine (5mC) or
5-hydroxymethylcytosine (5hmC), but not glucosyl-5-
hydroxymethylcytosine (g5hmC). Such preference is
in agreement with the biochemical determination of
the TagI modification dependence and the results of
phage restriction assays. The ability of TagI to digest
plasmids methylated by Dcm (C5mCWGG), M.Fnu4HI
(G5mCNGC) or M.HpyCH4IV (A5mCGT) suggests that
the SRA domains of the enzyme are tolerant to dif-
ferent sequence contexts of the modified base.
INTRODUCTION
Modification of DNA is commonly occurring in phages,
and examples have been found for variants of all four
standard DNA bases in their genomes. Modified bases
include 5-methylcytosine (5mC), N4-methylcytosine (4mC),
N6-methyladenine (6mA), 5-hydroxymethyluracil (5hmU)
and 5-hydroxymethylcytosine (5hmC), their glucosylated
variants (g5hmU and g5hmC), as well as several other already
demonstrated or predicted modified bases (1–4). Mech-
anistically, phages or other mobile elements can acquire
DNA modifications by passage in the host, or by incorpo-
ration of modified dNTPs into DNA, which can then be
optionally modified further. Cytosine C5 and N4 methy-
lation, as well as adenine N6 methylation can be acquired
after DNA synthesis in the host, or as a result of the ac-
tivity of orphan phage-encoded DNA methyltransferases
(MTases) (5). Other nucleobases like 5hmU and 5hmC are
incorporated directly by polymerase processing modified
triphosphates (6). Modified bases in phage or other mo-
bile DNAprovide protection against ‘conventional’ host re-
striction. For example, 2′-deoxyguanosine replacement by
2′-deoxyarchaeosine (dG+) in the Escherichia coli phage 9g
DNA renders it resistant to over 70% of commercially avail-
able Type II restriction endonucleases (REases) (7). Sim-
ilarly, -putrescinylthymine (putT) in phi W-14 DNA has
been found to block DNA cleavage by more than half of all
tested Type II REases (8). In addition to protection against
conventional restriction systems, modified DNA bases may
also have other functions, for example may facilitate pack-
ing of DNA in the phage head (9).
In response to the emergence of phages with modified
DNA, some bacteria have evolved REases that are directed
against such substrates. So far, examples have been found
for enzymes that specifically target modified adenine and
cytosine bases. Even for these bases, the modifications that
are shown to direct REase cleavage constitute only a sub-
set of the full repertoire of known modifications. Until
now, only 6mA, 5mC, 5hmC and g5hmC have been shown
to be targetable. Promiscuity for both adenine and cyto-
sine methylation has been inferred for Mrr from E. coli
based on genetic data, but not yet demonstrated in vitro
(10). Otherwise, modification-dependent REases appear to
be specific for either modified adenine or cytosine, but not
both.Methyladenine-dependent restriction has been clearly
demonstrated only forDpnI, a Type IIMenzymewith speci-
ficity for G6mATC target sequence (11,12). In addition, 6mA
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is known to play a role in phage growth limitation (Pgl)
systems, but the hypothesized 6mA-dependent REase has
not yet been identified (13). Some cytosine modification
dependent REases cleave highly GC-rich target sequences
containing several modified cytosines directly within the
recognition sequence (GlaI (14), BisI (15), Eco15I (15) and
EcoBLMcrX (16)). However, more typically, cytosine mod-
ification dependent REases cleave at considerable distance
from one or more modified cytosine bases. These enzymes
can be further divided into a group of nucleotide triphos-
phate dependent, hetero-oligomeric enzymes (McrBC (17–
19), GmrSD (20,21), SauUSI (22)) and a group of nu-
cleotide triphosphate independent homo-oligomeric en-
zymes.
The methylcytosine dependent, remote site cleaving,
NTP-independent REases include the McrA (RglA)
(23,24), MspJI (comprising also the distantly related Mrr)
(25) and PvuRts1I families (26,27). The REases in this
group tend to be two-domain proteins. The modifica-
tion dependence is determined by a specificity domain,
which is either of the SRA type (MspJI and PvuRts1I
groups) (28,29) or a new fold (McrA group) (30). The
McrA and MspJI specificity domains bind 5mC or 5hmC,
but do not accept g5hmC (25). In contrast, the PvuRts1I
SRA domain depends on 5hmC or g5hmC (26,27). For the
McrA specificity domain, the mechanistic basis of modifi-
cation dependence has not yet been determined. The SRA
domains of MspJI, PvuRts1I and similar REases flip the
modified nucleotide to scrutinize the DNA modification
(31,32). Sequence specificity in addition to the modification
dependence is present in some, but not all families. It has
been inferred from DNA binding experiments for E. coli
McrA (EcoKMcrA) (23) and is typical for the MspJI
family members (33). In contrast, PvuRts1I and similar
enzymes bind the modified cytosine irrespective of its
sequence context (27).
The nuclease domains in theNTP independent,modifica-
tion dependent REases are either of the HNH (McrA fam-
ily) or PD-(D/E)XK type (MspJI and PvuRts1I families).
Domain order varies. The nuclease domain comes first in
some (PvuRts1I), but not other (McrA and MspJI) fami-
lies (28,29,34). Sequence specificity of the nuclease domains
has not been reported for any of the enzymes. The distance
between sites of DNA modification and cleavage is accu-
rately defined in the MspJI and PvuRts1I families (25,27),
but variable for theMcrA family (24,30). Therefore, the first
two groups of enzymes are considered as Type IIM (recog-
nition of a modified base and cleavage at fixed distance),
whereas the McrA family is considered Type IV (recogni-
tion of a modified base and cleavage at variable distance)
(35).
Recently, SRA-HNH REases have been added to the
list of modification-dependent, remote site cleaving, NTP-
independent DNA endonucleases (36). The SRA-HNH
REases are characterized by the presence of an SRA (SET
andRINGfinger associated) domain (37) at theN-terminus
and an HNH (histidine-asparagine-histidine) domain (38)
at the C-terminus. Two enzymes from the family, ScoA3IV
from Streptomyces coelicolor A3 (Sco5333) and TbiR51I
from Thermobispora bispora (Tbis1) have been studied ex-
perimentally. Both were found to be toxic to Dcm+ E. coli
hosts. In the test tube, the enzymes bind at least 100-fold
better to DNA containing 5mC than to unmodified DNA,
and exhibit weak DNA cleavage activity in the presence of
Mg2+, Mn2+ and Co2+, but not Zn2+ ions (36).
Here, we present a biochemical and crystallographic
characterization of a putative SRA-HNH endonuclease
from the thermotolerant actinobacterium Thermocrispum
agreste, termed TagI (35). Our data show that TagI is
a member of the NTP-independent dimeric REases that
cleave DNA at a distance from the modified cytosine base.
TagI mediated DNA cleavage is enhanced by the presence
of another modified base. The SRA domain of TagI ac-
cepts 5mC and 5hmC, but not g5hmC. The TagI HNH domain
is so far unique among the nuclease domains of modifica-
tion dependentREases that cleave at a distance in exhibiting
sequence specificity. The crystal structure of TagI explains
the modification dependence, and preference for substrates
with at least two modified bases. The properties of TagI do
not fit conventional REase nomenclature and place it some-
where ‘in between’ Type IIM and Type IV enzymes.
MATERIALS AND METHODS
TagI gene cloning and purification
The synthetic tagIR gene with optimized E. coli codons
(IDT) was cloned into pTXB1 (NdeI-XhoI cut) by NEB
HI-FI assembly enzyme mix. The oligonucleotides used in
this work including cloning primers are listed in Supple-
mentary Table S1. The assembled DNA was transferred
intoDcm− E. coliB strain C2566 by transformation (NEB).
The same tagIR gene (a PCR fragment) was also cloned into
pET28b (Novagen) to generate a C-terminal 6xHis-tagged
version. The inserts were sequenced to confirm coding of
the desired amino acid sequences. TagI production was car-
ried out by IPTG induction overnight at 18◦C. TagI was
purified by chromatography through chitin (NEB) and Hi-
Trap heparin (GE Healthcare) columns.
Activity assays
Plasmid based assays. TagI restriction activity was first
assessed by digestion of 0.5–1 g of pBR322 (Dcm+ or
Dcm−), pBRFM+ (Dcm+) or pACYC-HpyCH4IVM+ plas-
mid in NEB buffer 2.1 (50 mM NaCl, 10 mM Tris–HCl,
10 mM MgCl2, 100 g/ml BSA, pH 7.9) at 37◦C for 1 h.
After the reaction Protease K (1.6 U) was added at 37◦C
for 15 min. The reactions were stopped by the addition of
the RE stop buffer. The partially digested pBR322 was se-
quenced to map the cleavage sites. For the digestions car-
ried out in the presence of Mn2+, 10 mM MgCl2 was re-
placed with 1 mMMnCl2. In the control experiments, 5 g
pBR322 was digested by 0.1 U of diluted DNase I in the
DNase I buffer. Digestions were carried out at room tem-
perature for 1, 2 and 5 min. The DNA was then subjected
to spin column purification and sequenced. Control enzyme
digestions (Fnu4HI, FokI, MspJI and MluCI) were carried
out based on standard protocols.
Cleavage assay on modified PCR DNA. DNA frag-
ments with 5mC or 5hmC (1.2 and 2.2 kb) were PCR
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and 5mdCTP/5hmdCTP replacing dCTP. 5hmC-containing
dNTPs were purchased from Zymo Research. 5mdCTP was
from NEB. The cleavage assays carried out in the presence
of Mg2+ were performed as above, i.e. in NEB buffer 2.1
at 37◦C for 1 h. The comparison of TagI activity in the
presence of various divalent metal ions was carried out in
0.1 M NaCl, 10 mM Tris–HCl (pH 7.5), 1 mM DTT, sup-
plemented with divalent cations or EDTA.
Cleavage assay on modified oligonucleotides. For the com-
parison of digestion efficiency in the presence of one or sev-
eral modified sites, we used four variants of the oligo 1 5′-
ATG CAG AAC AAG CCG AAT TAA TAG GCGGCC
GAA GCT TAT AGC ATT GAT-3′ and four variants of
the oligo 2 5′-ATC AAT GCT ATA AGC TTC GGCCGC
CTA TTA ATT CGG CTT GTT CTG CAT-3′ (GCSGC,
Fnu4HI and TagI cut site) (IDT). The variants differed in
the methylation status of the underlined cytosine bases. The
oligonucleotides were separately annealed in all combina-
tions to generate 16 different duplexes containing fromnone
to four methylated cytosines. The digestion was carried out
in the Mg2+ containing buffer at 37◦C for 30 min. The re-
action mixtures contained 1 l (20 ng, 32 nM) oligoduplex,
1 l TagI at 1/8 dilution (0.125 g, 92 nM), 2 l 10× NEB
buffer 2.1 and 16 l 10 mM Tris–HCl, pH 7.5. In the con-
trol digestions the same amount of oligoduplex was mixed
with 20 U of Fnu4HI endonuclease (GC/NGC).
TagI crystallization and data collection
Preliminary crystallization trials were performed in sitting
drops using a Phoenix robot and theMorpheus and JCSG+
screening conditions. TagI protein (5 mg/ml) in the buffer
containing 10 mM Tris–HCl, pH 7.5, 0.3 M NaCl, 5 mM
-mercaptoethanol (ME) and 0.5 mM EDTA, was mixed
in 1:1 ratio with reservoir buffers. Preliminary screening
identified 9 starting crystallization conditions. Since the
crystals obtained in sitting drops proved extremely frag-
ile and sensitive to manipulation, four conditions were se-
lected for crystallization in 1 mm diameter glass capillar-
ies. The best diffracting crystals were obtained by counter
diffusion of 25 l of the protein solution mixed with the
25 l of 0.5% low melting agarose dissolved in the above
buffer, and A5 Morpheus Screen (MDL) buffer (10% w/v
PEG 20 000, 20% v/v PEGMME 550, 0.03 MMgCl2, 0.03
M CaCl2, 0.1 M MOPS/HEPES-Na, pH 7.5). Tetragonal
crystals large enough to span the entire capillary diameter
appeared after 2 weeks. The crystals had very high solvent
content (70%) and were difficult to flash-cool. Therefore, a
diffraction dataset was collected in house at room tempera-
ture on an X8 PROTEUMBruker generator equipped with
a MICROSTAR micro-focus X-ray source (Cu K radia-
tion, 1.54 A˚). The crystal was rotated approximately around
the c-axis for quick completion of the dataset, which left
the 0 0 l reflections in the dead cone region. Data were in-
tegrated and scaled using the SAINT and SADABS pro-
grams (Bruker, Inc). Together with extinctions on the h00
reciprocal space axis, the 4/mmm Laue symmetry identi-
fied the space group as P42(1)2, P4(1)2(1)2, P4(2)2(1)2 or
P4(3)2(1)2. Data collection statistics are presented in Sup-
plementary Table S2.
Crystal structure determination
Models of the TagI SRA and HNH domains were built us-
ing the SWISSMODEL server (39), using the structures of
the human UHRF1 SRA domain (PDB code: 3clz (40))
and the human ZRANB3 HNH domain (PDB: 5mkw
(41)). The TagI structure was solved by molecular replace-
ment using the PHASER program (42). Due to the much
higher level of confidence in the model, the SRA domain
was placed before the HNH domain. The SRA domain
could also be oriented and positioned using the automatic
BALBES server (43). Both protocols identified the space
group as P4(1)2(1)2. The SWISSMODEL built HNH do-
main model (and alternatively also the original ZRANB3
fragment template) could then be placed using the FF-
FEAR program (44). The obtained composite models were
submitted to iterative model building with the BUCCA-
NEER (45) and ARP/wARP (46) programs which resulted
in the 90% complete model and R and Rfree of 21 and 27%.
Themodel was refined using the COOT (47) andREFMAC
(48) programs. The refinement statistics and quality indica-
tors are presented in Supplementary Table S2. The atomic
coordinates and the corresponding structure factors were
deposited at the PDB with the 6GHS accession code.
RESULTS
Expression and purification of TagI endonuclease
BLAST searches of publicly available sequence databases
using the well characterized SRA-HNH family REases,
ScoA3IV and TbiR51I as queries, identify several hun-
dred candidate endonucleases, most of them from Acti-
nobacteria, Bacteroidetes and Proteobacteria, and rarely
also from other bacterial phyla, including archaebacterial
ones. We selected the putative SRA-HNH endonuclease
from the thermotolerant, high GC-content, gram-positive
Thermocrispum agreste for our studies.T. agreste grows well
in a wide temperature range, between 28◦C and 60◦C (49).
This suggested that the enzyme may have the stability ben-
efits of proteins from thermophilic organisms, and yet be
active at 37◦C. TagI was recombinantly overexpressed from
a codon-optimized synthetic gene in E. coli, as an intein-
based self-cleaving chitin binding domain fusion protein.
TagI expression was well tolerated in Dcm− cells (T7 Ex-
press), but was toxic to Dcm+ cells, not only in the absence
of RecA (NEB 5, NEB 10), but also in its presence (NEB
Turbo) (Supplementary Figure S1). The enzyme was puri-
fied from whole cell extracts by chromatography on chitin
and heparin columns. Except where otherwise indicated, all
assays with the purified protein were carried out at 37◦C.
In vitro TagI dependence on metal cofactors and DNA mod-
ifications
The 5hmC-containing PCRDNAwas efficiently digested by
TagI in the presence of Mn2+, Co2+ and Ni2+ ions. The en-
zyme had lower activity in the presence of Mg2+ ions, and
no detectable activity in the presence of Zn2+ or Ca2+ ions
(Supplementary Figure S2). TagI activity was dependent
on the modification status of the substrate. In Mg2+ con-
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and, at high enzyme concentrations, also cleaved the non-
methylated plasmid (Supplementary Figures S3 and S4A).
Digestion was also observed for pACYC-HpyCH4IVM+
with A5mCGT methylation (from a Dcm− strain express-
ing M.HpyCH4IV), and was more efficient for pBRFM+
with additional G5mCNGC methylation (from a Dcm+
strain expressingM.Fnu4HI) than for onlyDcmmethylated
pBR322. The data show that TagI can cleave substrates con-
taining 5mC downstream of C (Dcm), G (M.Fnu4HI) or
A (M.HpyCH4IV), and variously staggered methyl groups
(Supplementary Figure S3). At high concentration, in high
temperature or in Mn2+ conditions, TagI exhibited star ac-
tivity and nicked/digested unmodified pBR322 (Supple-
mentary Figure S4).
The dependence of TagI activity on the type of cyto-
sine modification was tested using PCR products made
with either standard dNTP mix, or a mix containing either
5mdCTP or 5hmdCTP instead of dCTP. The PCR products
had slightly different length, so that their fates in digestion
reactions could be monitored independently. In the Mg2+
containing buffer, TagI cleaved the PCR products contain-
ing 5mC and 5hmC, but showed limited activity on unmod-
ified DNA. In the presence of Mn2+ ions, the enzyme pre-
ferred the modified substrates, but in agreement with the
results of the plasmid assays, in higher concentration also
digested unmodified DNA (Figure 1A).
Modification dependence of TagI activity tested on phage
DNA
TagI activity on phage DNA was consistent with the assays
on plasmids and PCR products. DNA containing either
5hmC (from glucosylation defective phage T4 (T4gt)), g5hmC
(from wt T4), or 5mC (from phage XP12) was subjected
to cleavage by TagI and control restriction endonucleases
(MspJI, MluCI and HpaII). The DNA from T4gt phage
was digested by TagI, MspJI (5mCNNRN9/) and MluCI
(/AATT), but not by HpaII (C/CGG, cleavage blocked by
5hmCmodification) (Figure 1B). The DNA that was derived
from intact T4 phage was resistant to MspJI and HpaII,
but not toMluCI digestion, as expected. Interestingly, 5hmC
glucosylation also blocked DNA cleavage by TagI. The 5mC
containing DNA from XP12 phage behaved as expected,
both in TagI and control digestions. The different outcome
of TagI digestions of DNA containing 5hmC and g5hmC was
reproduced in phage plaque assays. The expression of TagI
in E. coli cells had little effect on the outcome of infection
by phage Lambda or T4. In contrast, the infection by phage
T4gt was significantly attenuated (Figure 1C).
Mapping of TagI cleavage sites
Run-off sequencing can be used to map cleavage sites in
DNA. Themethod is based on the addition of an extra A by
the sequencing Taq DNA polymerase to the nascent strand
at the end of a template. A/C, A/G or A/T doublet or an
unusually strong A indicates a nick in the template strand,
on the 3′-side of the doublet with respect to the template,
and the 5′-side with respect to the read strand. Alternatively,
and equivalently, T/C, T/G, or T/A doublet or a strong T
in the reverse complement point to a nick in the displayed
strand, on the 3′-side of the ambiguous base (Supplemen-
tary Figure S5).
TagI cleavage sites weremapped for pBR322 (C5mCWGG
methylation) and pBRFM+ (G5mCNGC methylation) di-
gestions carried out at 37◦C and 50◦C. Although the plas-
mids were only sparsely methylated (chance occurrence
of C5mCWGG and G5mCNGC methylation sites for 50%
GC content is 1:512 and 1:256, respectively), many dou-
blets were found in close proximity of DNA modification
sites (at a variable distance less than 20 2′-deoxynucleotides
away). Nicking sites were detected in both strands in close
vicinity to each other, suggesting that a concerted double
strand break had occurred. In the majority of such cases,
the nicks were staggered to generate single nucleotide 3′-
overhangs in the digestion products (Supplementary Fig-
ure S5). The alignment of nicking sites indicated a prefer-
ence for a purine–pyrimidine dinucleotide step (/RY) im-
mediately downstream of the nick. The sequence for dou-
ble strand cleavage was RYN/RY, as would be expected for
single nucleotide staggered cuts and separate requirements
to match the /RY consensus for both strands (Figure 2). At
higher digestion temperature, suboptimal sites were more
easily cleaved. Therefore, sequence logos indicated a less
pronounced, but otherwise similar cleavage site preference
(Supplementary Figure S5D).
Sequence preference only for the region downstream of a
nick could be naturally explained by the polymerase pref-
erence (polymerase sees only one DNA strand, and only
the region downstream of the nick). Therefore, we used
the same protocol for run-off sequencing of control diges-
tions performed usingDNase I (non-specific endonuclease),
MspJI and FokI (REases cleaving an undefined sequence at
a specific distance from the recognition site). Neither the
DNase I nor the MspJI and FokI controls exhibited the
preferential nicking/cleavage on the 5′-side of a purine base
(Supplementary Figure S6), confirming that the sequence
logos for TagI DNA cleavage were not polymerase derived.
TagI crystal structure
TagI was crystallized in capillaries by counter-diffusion.
The crystals diffracted to 2.9 A˚ resolution, belonged to
space group P4(1)2(1)2 and contained a single TagI pro-
tomer in the asymmetric unit. The structure was solved by
molecular replacement and refined to typical quality indi-
cators for this resolution (Supplementary Table S2).
As predicted by the analysis of the amino acid sequence
(36), TagI consists of an N-terminal SRA domain and a C-
terminal HNH domain. The linker that connects the do-
mains (residues 168–192) is not represented by electron den-
sity in the crystals, presumably due to disorder. This cre-
ates some uncertainties about the assignment of domains to
polypeptide chains. We have assumed that the linker con-
nects the closest C-terminal SRA and N-terminal HNH
ends, however, the region of missing electron density would
also be sufficient for an alternative assignment (Figure 3A).
Irrespective of how the domains are connected, it is likely
that their packing against each other is determined by crys-
tallization forces. The PISAweb server (50) does not classify
any interaction between the SRA and HNH domains (irre-
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Figure 1. TagI activity assays on (A) 5hmC and 5mC containing PCR products and (B,C) modified phage DNA in vitro and in vivo. (A) One g of mixed
PCR DNA (∼12 nM) made from modified dNTP mixtures was digested at 37◦C for 1 h with 1 g TagI (∼0.3 M) in 2-fold serial dilutions in NEB buffer
2.1. The substrates for TagI digestion in 10 mMMg2+ contained C (3 kb) and 5hmC or 5mC (2.2 kb). The assay in 1 mMMn2+ was performed on C (3 kb),
5hmC (2.2 kb) and 5mC (1.2 kb) containing PCR DNA. The amount of TagI (g) shown on top of each lane corresponds to 295, 147, 74, 37, and 18 nM of
protein dimer, respectively. (B) Modified DNA from phage T4gt (5hmC,∼0.2 nM), T4 (g5hmC,∼0.2 nM) or XP12 (5mC, 0.5 nM) was digested by TagI (∼0.3
M) and control enzymes: tolerant to the presence of modified cytosines (MluCI (/AATT), 10 U), inhibited by cytosine modifications (HpaII (C/CGG),
10 U) and affected only by the presence of g5hmC (MspJI, 5U). (C) Late-log phase host cells were plated on soft agar to form a cell lawn, and diluted phages
(Lambda, T4gt or T4) were spotted onto the cell lawns. Cell lysis and plaque formation indicated susceptibility to phage infection. No plaque formation
indicated the restriction of T4gt phage by TagI expressing cells.
kcal/mol). This result suggests that the domains are mobile
with respect to each other, in agreement with the biochem-
ical result that TagI can cleave DNA at a variable distance
from the modified DNA base.
TagI crystals contained a dimer located on a crystallo-
graphic two-fold axis and mediated by the interactions be-
tween the HNH domains. In contrast to the interaction be-
tween N- and C-terminal domains of the enzyme, the PISA
web server (50) classifies the dimerization as biologically
relevant. According to the PISA prediction, the interface
area of the dimer is 1520 A˚2 and the estimated free energy
of dimer formation equals –12.8 kcal/mol. (Figure 3A).
A model of TagI with DNA molecules bound to the SRA and
HNH domains
The TagI SRA domain can be described, similarly to the
prototypical UHRF1 SRA domain (26), as a distorted 
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Figure 2. Sequence logo for TagI ds cleavage (left) or nicking (right) ac-
tivity. 16 double strand cleavage sites (A) and 31 nicking sites (B) were
combined from pBR322, pBRFM+, and 5hmC PCR DNA cleavage per-
formed at 37◦C. The arrow denotes the site of DNA cleavage or nicking.
Note a systematic bias in the determination of the sequence logos. An A
base immediately downstream of the cleavage site is detected with lower
efficiency (because the polymerase incorporates the correct base, albeit in
a template-independent manner).
Figure 3. Experimentally determined structure of TagI in the absence of
DNA (A) and a model of TagI with separate DNA fragments bound to the
SRA and HNH domains (B). The TagI protomer in the asymmetric unit
is shown in yellow (SRA domain) and green (HNH domain), the crystal-
lographic symmetry mate that completes the TagI dimer is shown in light
gray. The fragment of the structure that is disordered in the crystal is in-
dicated by a dashed line. The unit cell and the directions of the crystallo-
graphic axes are shown in gray. The DNA molecules that have been mod-
elled in complex with the SRA domains of the dimer are shown in gold
and light gold color, and the single modelled DNAmolecule that is bound
to the HNH dimer is shown in dark grey color.
cent strands that should, but do not actually engage in main
chain hydrogen bonding interactions. Thanks to the conser-
vation of the dsDNA binding mode to the SRA domains
(Supplementary Figure S7), the TagI SRAdomainDNA in-
teraction could be modelled with confidence. Among SRA
domains of known structure, TagI is most similar to the hu-
man UHRF1 SRA domain, which has been crystallized by
several groups in complex with dsDNA (1,40,51). The high
sequence similarity between the two domains (42% amino
acid identity over 194 residues), and conservation of key
residues involved in DNA binding, support the model for
the DNA complex of this domain (Figure 3B). Assuming
flexible linkers between SRA and HNH domains, the two
SRA domains may bind modified bases in opposite strands
of the sameDNAduplex. However, modelling suggests that
this binding mode is dependent on the stagger of modi-
fied bases, and is possible for fully methylated 5mCG and
5mCNG, but prevented by clashes for fullymethylatedG5mC
and GN5mC sequence contexts (Supplementary Figure S8).
The TagI HNH domain is built around the core -Me
motif of HNH endonucleases. The binding mode of DNA
to the HNH domain of the enzyme was more difficult to
model, due to the relatively low level of conservation be-
tween this domain and HNH domains that have been crys-
tallized in complexwithDNA.For themodel, we took guid-
ance from the structures of Hpy99I (52), I-PpoI (53) and
T4 endonuclease VII (54). In all these protein complexes,
the DNA is bent in a similar manner, with a widened mi-
nor groove, making it likely that the same distortion occurs
also in the TagI DNA complex. The DNA bound to the
TagI nuclease domains is likely canonically stacked, since
the preferred target sequence with alternating purine and
pyrimidine bases is not conducive to base stack rearrange-
ments as in the PacI structure (55). Using the bent DNA
from the Hpy99I complex, and the knowledge of the cleav-
age stagger (single nucleotide 3′-overhangs), we generated
a model of the TagI HNH domain dimer with specifically
bound DNA (Figure 3B).
The modelled DNA duplexes bound to the SRA and
HNHdomains do not align.Moreover, the regions of DNA
bound to the two domains cannot be connected so that the
distance between modification and cleavage site is only ∼8
nucleotides, i.e. the minimum distance that was found in
the sequencing studies. The conclusion remains valid for al-
ternative linker connections. We interpret this result as fur-
ther evidence that the relative orientation of TagI SRA and
HNH domains in the crystal may correspond to only one
of many relative orientations that we expect to occur in so-
lution.
Predicted TagI SRA domain DNA interactions
The interaction of the SRA domain with DNA resembles
a hand grasping the DNA with ‘finger’ and ‘thumb’, both
built from loops linking the strands of the -sheet and the
flanking -helices (Figure 4 and Supplementary Figure S7).
The ‘finger’ of the SRA domain is also called the ‘NKR’
finger (40) or ‘CpG recognition loop’ (51) according to its
amino acid sequence and functional role in the prototypical
SRA domains of UHRF1 and UHRF2. However, the sig-
nature motif and role in CpG sequence specificity are not
universal among the SRA domains. The equivalent loop in
the MspJI group of enzymes is known as ‘loop 6C’ (31).
Compared to UHRF1, the finger of the TagI SRA domain
is much shorter and more compact. The equivalent of the
NKR signature sequence of this loop in TagI is KKQ. The
glutamine is not spatially equivalent to the arginine, which
in the UHRF1-DNA complex interacts with the Hoogsteen
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Figure 4. Sequence alignment (A) and structure of TagI (B), UHRF1 (40) (C) andMspJI (31) (D) SRA domains. The models are in ribbon representation.
Key loops and selected functionally important residues are highlighted. The DNA in panel B is not present in the crystals and was modeled based on the
UHRF1-DNA complex shown in panel C.
The ‘thumb’ of the SRA domain is also known as the
‘base flipping promotion loop’ (51) because a residue an-
chored in this loop typically displaces the flipped base,
or as ‘loop B3’ in the MspJI family of REases (28,33).
The ‘thumb’ loop interacts with the DNA from the minor
groove side. In TagI, Gln35 from this loop should fill the
space of the flipped base, and appears well positioned to
form two hydrogen bonds with the Watson–Crick edge of
the estranged guanine base. In TagI, the thumb loop also
anchors a histidine residue, His33, which could reach into
the outer minor groove of the bound DNA or serve as a
backbone binding residue.
Some SRA domains are specific for DNA sequence in the
vicinity of the modified DNA base, e.g. 5′-5mCNNR-3′ for
MspJI, 5′-YS5mCNS-3′ for AspBHI, and 5′-C5mCDG-3′ for
LpnPI (33). The structural basis for this specificity is best
understood in case of MspJI, which has been crystallized
together with modified DNA. The specificity appears to be
mediated by a favorable hydrogen bond of the so-called loop
78, which anchors Lys173. There is also a hydrogen bond
fromGln33 to a universal hydrogen bond acceptor position
in the DNA. The interacting residues are not conserved in
TagI, and the corresponding loops are slightly further away
in the TagI apo structure than in theMspJI-DNA complex.
The conservation of the loops between TagI and UHRF1-
DNA structures supports the conclusion about their con-
formation (Figure 4). The TagImodel also predicts that a -
hairpin (approximately residues Gly37 to Val50 and a part
of the distorted barrel) reaches towards the modelled DNA.
The current model favors interactions of these residues with
the DNA backbone over interactions with the minor grove
edges of theDNAbases (Supplementary Figure S9). Never-
theless, we think that the model is not sufficiently accurate
to exclude interactions that may mediate sequence speci-
ficity.
Predicted TagI SRA domain pocket and specificity
SRA domains extrude the modified base from the base
pair stack and bind it in a dedicated pocket. In the case
of TagI (and in UHRF1), the walls of the pocket for the
flipped base are built from tyrosine residues, Tyr55 and
Tyr67. Here, the former tyrosine is rotated out from its po-
sition in the UHRF1 SRA domain, creating a slightly wider
pocket similar to the one observed in UHRF2. As in other
SRA domains, the Watson-Crick edge of the flipped base
engages in several hydrogen bonds, with both main chain
and side chain atoms. The most characteristic interaction
is the hydrogen bond(s) with a carboxylate (of the aspar-
tate in UHRF1 and glutamate in UHRF2). In the crystal
structure of TagI, Asp58 is perfectly positioned to play this
role (Figure 5, top). The interactions of the Watson–Crick
edge of the base with the carboxylate are responsible for
the preference for amodified cytosine over thymine. Assum-
ing the sameDNA backbone conformation, purines should
also not be tolerated in this position because of their larger
volume, which would lead to steric conflicts with the aspar-
tate.
TagI cleaves DNA containing either 5mC or 5hmC, with a
slight preference for 5hmC. The model shows that the SRA
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Figure 5. Specificity of the flipped base binding pockets in the SRA domains of TagI (A), UHRF1 (40) (B), UHRF2 (64) (C) and PvuRts1I (29) (D). Upper
panels show the key residues forming the flipped base binding pockets. Lower panels depict the surface of the pockets. The TagI SRA domain surface was
colored according to the sequence conservation calculated by the ConSurf server (57). The position of the flipped nucleotide in the TagI and PvuRts1I
pockets is not based on experimental structure, but inferred from the binding mode of 5hmC to human UHRF2. The g5hmC residue was modelled based
on the NMR structure of -D-glucosylated DNA (65). The binding modes of the 5mC in UHRF1 and 5hmC in UHRF2 are based on crystal structures.
cytosine in the pocket. The preference for 5mC over C is pre-
sumably due to hydrophobic interactions and solvation ef-
fects, since the model places the methyl group in a fairly hy-
drophobic environment in the immediate vicinity of the side
chains of Ile38 and Tyr67. The preference for DNA con-
taining 5hmC could be due to formation of a hydrogen bond
from the 5hmC hydroxyl group to the main chain carbonyl
oxygen atom of Thr68. The threonine lies in a highly con-
served region. Therefore, the explanation predicts a univer-
sal preference of SRA domains for 5hmC, in contrast to the
experimental observations. We think that a ‘general’ SRA
preference for 5hmC over 5mC is countered in some, but not
all SRA domains by the conformation of the first of the two
aromatic residues (Tyr55 in TagI, Tyr466 in humanUHRF1
and Phe495 in human UHRF2). It can adopt an ‘in’ con-
formation as in UHRF1 that collides with 5hmC, or an ‘out’
conformation as in UHRF2 or TagI that leaves space for
the hydroxyl group. The choice between ‘in’ and ‘out’ con-
formation appears to depend on the local environment, and
not onwhether the residue is phenylalanine or tyrosine (Fig-
ure 5, top).
TagI does not cleave DNA containing g5hmC, in contrast
to enzymes of the PvuRts1I family, which accept and even
prefer the presence of 5hmC glucosylation. Modelling indi-
cates that a glucosyl group would clash with TagI in the
region of Thr68-Gly71 residues. This region adopts a sim-
ilar conformation in UHRF1, but differs substantially in
PvuRts1I, which has enough space for the glucosyl group.
Further regions that may be involved in the g5hmC discrim-
ination comprise residues 35–39 and 89–92 of TagI. The
first region adopts slightly more favorable conformation in
PvuRts1I and the second is almost completely missing. In
summary, we predict that the lack of activity of TagI to-
wards g5hmC is at least in part caused by the SRA domain,
but we of course cannot exclude that the HNH domain may
separately rejectDNAwith thismodification (Figure 5, bot-
tom).
TagI HNH domain
The TagI HNH domain is organized around two divalent
metal cations, a structural Zn2+ ion and a catalytic divalent
metal ion (Figure 6). The identity of the latter ion in the
crystal is uncertain, but we tentatively interpret it as a Na+
ion. Mg2+ or Ca2+ ions were also present in the crystalliza-
tion buffer, but their concentration wasmuch lower than for
EDTA, and thus they weremost likely chelated and unavail-
able for the enzyme.
The structural Zn2+ ion in TagI is coordinated by three
cysteines, presumably in the thiolate form, and an aspartate
(Figure 6). The sequential spacing between themetal chelat-
ing residues is typical for the Zn2+ binding motif in HNH
endonucleases and many other Zn2+ chelating proteins in
general (41,52,56). The Cys210 and Cys213 residues of TagI
form a classical CxxC motif. Replacement of either of the
two cysteine residues by an alanine drastically reduced the
activity, so that at the highest tested concentrations, at most
nicking or linearization of a Dcmmethylated pBR322 plas-
mid were observed (Supplementary Figures S10 and S11).
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Figure 6. HNH domain of TagI (A) and of the Hpy99I REase with bound DNA (52) (B), and sequence alignment of selected HNH nucleases (C). The
-Me motif that is characteristic for the HNH nucleases is highlighted by more intense coloring. Selected active site residues and the ligands of the
structural Zn2+ ion are indicated. In panel (B), only the dinucleotide around the scissile phosphodiester bond is shown.
Zn2+ binding sequence, that requires only slight backbone
changes compared to the classical CxxC motif, since the
cysteine and aspartate side chains have similar lengths. The
TagI CxxD motif is not characteristic for the entire family
of SRA-HNH endonucleases. Other family members have
either a conventional CxxC motif (e.g. ScoA3IV) or a func-
tionally equivalent CxxHmotif (e.g. CflDI putative endonu-
clease, GeneBank code: ADG74130.1) (Figure 6C) (36).
The catalytic divalent metal ion, or the surrogate Na2+
ion in the crystals, defines the location of the active site,
which is anchored in the typical  motif that has given
rise to the alternative -Me designation for HNH en-
donucleases (Me stands for the metal ion). TagI is a ‘canon-
ical’ HNH endonuclease, because the moniker histidine, as-
paragine and histidine residues are present as suggested by
the nuclease family designation and not replaced by func-
tionally equivalent residues (Figure 6).
The first histidine of the HNH motif, His229 in TagI,
is typically considered as the residue that activates the
nucleophilic water for the phosphor-ester scission (52,53).
In the TagI structure, this histidine is held in place by a hy-
drogen bond (or a salt bridge) to Asp241. The nucleophile
activating His229 of TagI, is found in the secondary struc-
ture context typical for HNH endonucleases, i.e. at the end
of the first -strand (residues 226–229) of the -Me mo-
tif. The asparagine of the HNH motif is frequently con-
served, but has no catalytic role (52). Asn245, the corre-
sponding residue in TagI, is hydrogen bonded with main
chain of Arg231 and may help to stabilize the catalytic core
motif. The second His residue of the HNH motif, His254
in TagI, is involved in the coordination of the active site
metal. All three residues are essential, as judged from se-
quence conservation and site-directed mutagenesis (Figure
6, Supplementary Figures S10 and S11, Supplementary Ta-
ble S3).
Additional coordination of the metal ion is interesting.
In many HNH endonucleases, an acidic residue directly up-
stream of the first histidine of the HNH motif is a first
shell ligand of the active site metal ion. However, Ala228 in
TagI is not suitable for this role. Instead, an acidic residue,
Asp258, located three amino acids downstream of the last
histidine of the HNH motif, appears to take this function.
An aspartate residue in this position is present also in sev-
eral other SRA-HNH endonucleases, including the proto-
typical ScoA3IV, but not all enzymes in the family (36).
The activity assay confirms that the TagI aspartate is re-
quired for activity (Figure 6C, Supplementary Figures S10
and S11).
Prior to the structure determination of TagI, we also pre-
pared H237A, N259A and H288A variants of the enzyme.
His237 is located close to the HNH dimer interface, ∼11 A˚
away from the expected position of the scissile phosphate.
When the residuewas replaced by alanine,more activity was
retained than in the case of the active site mutants (Supple-
mentary Figure S10). The N259A and H288A variants had
only very weak activity, and were at most able to nick or lin-
earize the test substrate. Asn259 engages in hydrogen bond
formation at the dimer interface and lies immediately down-
stream of Asp258, one of the residues that bind the catalytic
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prising. His288 is located at the surface of TagI, away from
the active site, predictedDNAbinding region and dimeriza-
tion interface. The strong effect of an exchange of His288 is
therefore difficult to explain (Supplementary Figure S11).
Predicted TagI HNH domain DNA interactions
The RYN/RY consensus sequence around TagI cleavage
sites lies within in the estimated footprint of the HNH
dimer. Therefore, the specificity for the bases in the imme-
diate proximity of the cleavage site must stem from interac-
tions of the HNH domains with the DNA. Unfortunately,
the TagIHNH-DNAmodel is less confident than that of the
SRA domain and does not make it possible to predict de-
tailed interactions. Nevertheless, some general conclusions
can be drawn. In the model, there are no clear contacts be-
tween TagI and the central base pair of the recognition se-
quence. However, several TagI residues, all with a possibility
to engage in sequence selective hydrogen bonding interac-
tions, come close to the other bases of the recognition se-
quence.
Arg194, which inserts into the major groove of the bound
DNA in the model, makes contact with the +1 purine of the
recognition sequence (i.e. the R immediately downstream of
the central nucleotide). However, inaccuracies in the model
make it also possible that Arg194 may interact with the
base pairs in ±2 positions. Moreover, this residue is at the
end of the ordered part of the inter-domain linker that is
likely to adopt different conformation in the DNA com-
plex. Gln226, the residue that forms hydrogen bonding in-
teraction withHis254 coordinating the active site metal, ap-
proaches the DNA from the minor groove side. Lys129 and
a carbonyl oxygen atom of the linker could also come close
to the DNA. Finally, it is possible that the linker may be-
come ordered in the catalytic complex and may contribute
additional sequence specific interactions upon DNA bind-
ing.
TagI oligomerization and DNA binding in solution
In order to check the oligomeric state of TagI in solution, we
carried out analytical gel filtration experiments, either for
TagI alone, or in the presence of unmodified, hemi- or fully-
methylated 17mer DNA duplexes (modified in the 5mCNG
context) (Supplementary Figures S12 and S13). TagI alone
migrated with an apparent molecular mass of 68 ± 3 kDa,
close to the theoretical 67.9 kDa mass of the protein dimer
(Supplementary Figure S14). Multi-angle light scattering
(MALS) confirmed the molecular mass of 68 ± 3 kDa, in
excellent agreement with expectation (Supplementary Fig-
ure S15). As foreseen, oligoduplexes alone migrated faster
than expected due to the elongated rod shape (at the appar-
ent mass of 22 kDa in contrast to the calculated mass of 10
kDa). When TagI and unmodified DNA were co-injected,
they migrated independently in any tested stoichiometric
ratio (1, 2 or 4 DNA duplexes per TagI dimer). Co-injection
of TagI and hemi-methylated DNA (either strand methy-
lated) led to a broad peak for complex and to a sharper peak
forDNAalone (whenDNAwas present in excess). The data
suggest that there was equilibrium between unbound TagI
and the protein bound to hemi-methylated DNA. In con-
trast, co-injection of TagI and fully methylated DNA re-
sulted in sharp peaks for the complex (apparent mass of
93 kDa) and unbound DNA (when DNA was present in
excess). We conclude from these data that fully methylated
DNA bound more tightly to TagI than hemi-methylated
DNA. At most slightly more than one duplex of DNA
per TagI dimer co-migrated, even when DNA was present
in several-fold excess. The tighter binding of fully methy-
lated DNA and the unexpected saturation already at one
DNA duplex per TagI dimer indicated that one SRA do-
main could be bound to each DNA strand of the duplex.
This interpretation was additionally supported by the pres-
ence of a small peak at still lower retention time (corre-
sponding to the apparent mass of ∼220 kDa), which was
most likely due to two TagI dimers bound to a single DNA
duplex (or other super-complexes). The interpretation that
two SRA domains of a TagI dimer could be bound to two
methyl groups of a fully methylated DNA duplex was in
agreement with the modelling result that two SRA domains
could be placed on fully methylated 5mCNG DNA without
serious clashes (Supplementary Figure S8).
Guidance of TagI by one or two DNA modifications
The architecture of TagI with two SRA domains that sepa-
rately bind duplex DNA, but only a central (dimeric) HNH
nuclease, suggested that the enzyme may cleave DNA more
efficiently when guided by two instead of a single modi-
fied base. In order to test this hypothesis, we compared the
cleavage of oligoduplexes that had a GCSGC site compati-
ble with the TagI RYN/RY nuclease specificity, flanked by
either unmodified or methylated cytosines in top and bot-
tom strands separated from the cleavage site by 11 or 12
nucleotide spacers (5′-N11-GCC-N10-GCGGC-N11-GCA-
N5-3′ and 5′-N6-GCT-N10-GCCGC-N11-GCT-N10-3′). In
this way, all 24 = 16 combinations of methylation at the four
sites could be separately probed. The digestions were car-
ried out in the presence of Mg2+ ions to keep the reaction
rates relatively low and to concentrate cleavage at a consen-
sus GCG/GC sequence between the two modification sites
(Figure 7). Under these conditions, the control oligoduplex
without DNA modifications was not cleaved at all.
Oligoduplexes containing only a single 5mC were hy-
drolyzed slowly. Interestingly, a single 5mC could direct
cleavage either upstream or downstream of the modified
base. Oligoduplexes containing at least two 5mCs could be
divided into two groups. Those that had two neighbor-
ing 5mCs in top and bottom DNA strand were cut ineffi-
ciently, like the ones containing only a single 5mC, presum-
ably because the sequence context was (arbitrarily) chosen
as G5mC, which should not be compatible with simulta-
neous binding of two SRA domains to a fully methylated
site (Supplementary Figure S8). We expect that for 5mCG
and 5mCNG sequence contexts, such oligoduplexes should
be efficiently cleaved. All duplexes with 5mC modifications
at a distance (28 bp in our experimental conditions) were
hydrolyzed efficiently. For such substrates, cleavage was ef-
fective for symmetry compatible modifications on opposite
strands and symmetry breaking modifications in the same
strand. The enhancement rate appeared to be more than
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Figure 7. Efficacy of DNA TagI cleavage of substrates containing none to four 5mC bases. 20 ng (∼32 nM) of annealed 48-mer oligonucleotides were
digested by TagI (0.125 g, ∼92 nM of TagI dimer) in NEB buffer 2.1 for 30 min. Cleavage products were resolved in 15% urea-PAGE, stained by SYBR
Gold and imaged on Typhoon imager. The predicted TagI cleavage site GCS/GC at the center of the duplexes conforms to the GC/NGC consensus for
cleavage by Fnu4HI (20 U), which was used as a positive control. 5mCs in oligoduplexes are represented by small black dots in the diagrams above each
lane.
and therefore was unlikely to result from twice more effi-
cient nuclease recruitment alone.
Oligoduplexes containing three or more 5mC sites neces-
sarily contained at least one pair of 5mC sites in mutually
supportive positions. As expected based on the results for
the duplexes with exactly two distant 5mCs, all were cleaved
efficiently. We conclude that TagI works optimally under
the guidance of two modified cytosine bases flanking a con-
sensus cleavage site, irrespective of which strand the methyl
groups are placed in (Figure 7).
An unbiased screen for inactivating TagI modifications
TagI is toxic to Dcm+ cells, in both RecA+ and RecA−
(DNA repair deficient) background. We used error-prone
PCR with Mn2+ instead of Mg2+ ions to introduce mu-
tations in the TagI gene, and scored the resulting expres-
sion constructs for toxicity to E. coli cells. Plasmids ex-
pressing ‘non-toxic’ TagI were then sequenced (Supplemen-
tary Table S3). As cells can repair nicks more easily than
double strand breaks, it was expected that some TagI vari-
ants could retain nicking activity. It was indeed found that
some of them clearly retained the property. Variants were
surprisingly evenly distributed across the entire TagI en-
zyme, and did not cluster at the active sites or predicted
DNA binding regions. For the relatively small number of
characterized variants, there was also no clear correla-
tion with conservation scores calculated using the Consurf
server (57) (Supplementary Figure S16).
DISCUSSION
A model for TagI activity
Our combined data suggest a simple model for TagI activ-
ity. We attribute the modification specificity to the SRA do-
mains, and the RYN/RY specificity to the HNH-domain
dimer. We expect that the TagI SRA domains anchor the
enzyme to sites of DNAmodification.Whether they exhibit
sequence specificity like many better-characterized SRA
domains (1,33,40,51) remains currently unknown. How-
ever, the in vitro activity on DNA that has been methy-
lated by Dcm (C5mCWGG), M.Fnu4HI (G5mCNGC) or
M.HpyCH4IV (A5mCGT), suggests that the TagI SRA do-
main can bind to DNA that is modified in various sequence
contexts. For physiologically relevant (low) TagI concentra-
tion, we expect that cleavage occurs only when the nuclease
domains encounter a target site and are co-anchored to this
site by one or two DNA modifications. As the TagI dimer
has a single DNA binding site in the nuclease domains, but
two separate binding sites formodified cytosines in the SRA
domains, it is unsurprising that two suitably spaced modi-
fied bases can direct DNA cleavage at a single recognition
sequence more efficiently than a single modified base. The
guidance from two modification sites may also explain the
efficient cleavage of heavily modified PCR DNA or phage
DNA such as XP12 and T4gt.
Our model of TagI activity is not readily compatible with
the standard classification of REases (35). The enzyme can
be described as a Type IV REase, because it cleaves DNA
at a distance from a site of modification. However, the en-
zyme also exhibits features of a standard Type II REase
with defined target sequence, although semi- or full degen-
eracy in every single position are not typical. TagI cannot
be described as a Type IIMREase, because the definition of
such enzyme requires that the modification must be present
within the target sequence.
Properties of modular, NTP-independent, modification de-
pendent REases
The modular architecture of TagI is widely shared among
the NTP-independent, modification-dependent endonucle-
ases. TagI shares an HNH domain as the nuclease domain
with the EcoKMcrA (MCRAN-HNH) family (34,30), and
the SRA domain with the PvuRts1I (PD-(D/E)XK–SRA)
(29,58,59) and MspJI/Mrr (SRA–PD-(D/E)XK) (28,31)
families.
The non-catalytic domains in these fusion proteins bind
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Table 1. Properties ofmodification dependentREase groups. Themodification dependentREasesmay be classified according to their domain organization.
The three best known groups of modified cytosine dependent REases are characterized by similar modification, distance and sequence preferences

















SRA - HNH unknown 5mC, 5hmC broad YES YES NO
TagI unknown 5mC, 5hmC 9-23 RYN/RY YES NO
McrAN - HNH YES 5mC, 5hmC broad broad NO NO
EcoKMcrA (Y)5mCGR 5mC, 5hmC broad broad NOa NO
SRA - PD-(D/E)XK YES 5mC, 5hmC defined broad NO NO
MspJI 5mCNNR 5mC, 5hmC 12 broad NO NO
AspBHI YS5mCNS 5mC, 5hmC 10 broad NO NO
LpnPI C5mCDG 5mC, 5hmC 12 broad NO NO
PD-(D/E)XK - SRA NO 5hmC, g5hmC narrow broad YES YES
PvuRts1I NO 5hmC, g5hmC 11-13 broad YES YES
AbasI NO 5hmC, g5hmC 11-13 broad YES YES
aThe enhancement of EcoKMcrA activity by multiple modification sites is not observed in vitro. However, the activity of the enzyme in the test tube is low
and it remains possible that its natural substrate has not yet been identified.
ment for 5mC or 5hmC, but not 5ghmC, TagI exhibits sim-
ilar modification dependence as the EcoKMcrA (30) and
MspJI/Mrr families (25), but not the PvuRts1I family
(26,27). Thus, modification specificity does not segregate
according to phylogeny. Typically, but not universally, the
modification-dependent, non-catalytic domains have some
sequence specificity (in the EcoKMcrA and MspJI/Mrr
families, but not in the PvuRts1I family) (27,33,30). The
sequence specificity of the non-catalytic TagI domains is
not yet fully clear, but we know already that the en-
zyme can cleave DNA which is methylated in C5mCWGG,
G5mCNGC and A5mCGT sequence contexts (the C oppo-
site to the underlined G is also modified), suggesting that
the TagI SRA domain has broad sequence specificity (Ta-
ble 1).
The catalytic domains of the modular, modification de-
pendent and NTP-independent REases are generally as-
sumed to be sequence non-specific. TagI is unusual in
this respect, because the nuclease domains exhibit clear
sequence preference, both for nicking and double strand
breaks. In the small sample of modification dependent
REases studied to date, fixed distances between modifica-
tion and cleavage sites, and nuclease sequence preferences
appear anti-correlated. This may not be accidental, since
both bring down the number of cleavage sites, perhaps to
balance toxicity for the host with efficacy against invading
DNA (Table 1).
In all families of modification dependent REases dis-
cussed here, the nuclease domains dimerize, but the non-
catalytic domains do not (28–30). As a result, the nucle-
ase domains form a joint DNA binding site, whereas the
non-catalytic domains expose separate sites. The architec-
ture suggests that DNA double strand breaks can be con-
trolled by up to two modified bases. The MspJI family is
generally considered to require only a single modified base
(25), and this may also apply to the EcoKMcrAREases, for
which the physiological substrate is still uncertain (30). In
contrast, the PvuRts1I family operates optimally when two
suitably spaced modified DNA bases direct DNA cleavage
(27). However, the requirement for two sites is not rigorous,
otherwise the enzyme could not be used to map 5hmC in eu-
karyotic DNA (26,27,60), despite the rarity of the modi-
fied base (61,62). With respect to the number of modified
bases required for optimal cleavage, TagI is thus most simi-
lar to the PvuRts1I family in being aided by, but not depen-
dent on two modified DNA bases. At least in the canoni-
cal PvuRts1I substrates, modifications have to be symmet-
rically arranged (on the opposite DNA strands) (27). This
is not the case for TagI, which cleaves substrates with two
modified bases in the same strand with similar efficiency as
substrates with modifications on opposite strands.
Biological implications
In view of the likely limited selectivity of TagI for the se-
quence context of the modified base, it appears surprising
that it is not toxic to the host. The potential conflict between
C5-methyltransferases and TagI appears to be avoided by
the absence of the former. The BLASTP or TBLASTN
(63) search of the T. agreste proteome or genome, using
the E. coli Dcm protein sequence as a query, did not iden-
tify hits that are likely to encode DNA methyltransferases.
Therefore, it is plausible that T. agreste lacks Dcm methy-
lation, and perhaps all C5 genomic methylation, and can
thus tolerate the TagI activity. In the Streptomyces coeli-
color A3(2) genome, where the prototype SRA-HNH en-
donuclease ScoA3IV was first discovered, there is one puta-
tive C5 methyltransferase gene (ScoA3ORF6844). S. coeli-
colorA3(2) carries three 5mC-dependent restriction systems,
namely ScoA3I (unverified, SauUSI-like), ScoA3IV, and
ScoMcrA (36). It is therefore likely that ScoA3ORF6844 is
not an active DNAmethyltransferase, which would be con-
sistent with the presence of an SPPC instead of the canoni-
cal GPPC active site motif (motif IV) in its sequence.
The 5hmC and g5hmC bases are typically only found
in phage DNA. 5hmC is synthesized by the phage from
a mix of dNTPs, with 5hmdCTP instead of dCTP. The
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monophosphate, and is catalyzed by a deoxycytidylate 5-
hydroxymethyltransferase (dCMP HMase) with similarity
to folate dependent thymidylate synthases (6). Using the T2
phage dCMP HMase as the query, we confirmed the ab-
sence of similar proteins from the T. agreste proteome, thus
excluding the possibility of 5hmC production from an inte-
grated prophage.
It is currently somewhat unclear what exactly TagI de-
fends its host against. T. agreste, the producer organism
of TagI, belongs to the Actinomycetales, an order of Acti-
nobacteria. BLAST searches using TagI as a query con-
firm that this origin is typical, and that many other SRA-
HNH endonucleases are found in Actinobacteria, Bac-
teroidetes and Proteobacteria. Abundant d5mCMP instead
of dCMP may be present in Achromobacter, Roseobac-
ter, and Xanthomonas phages (6), that are known to infect
Proteobacteria only. Enzymatic machinery to generate the
5hmCTP building block is present in T4, T4-like, Enterobac-
teria,Xanthomonas,Aeromonas and Salmonella phages that
also infect Proteobacteria. g5hmC has been detected in the
genomes of various phages. Non-glucosylated 5hmC has so
far not been found in phage genomes, but genomic data sug-
gest that some phages may have enzymes to generate 5hmC
and may lack the activity to glucosylate it (6).
The taxonomic mismatch between the origin of TagI
and many related SRA-HNH endonucleases on the one
hand, and the origin of phages with hypermodified genomes
containing either 5mC or 5hmC on the other hand, is sur-
prising. It may suggest that TagI is primarily directed
against sparsely C5-methylated phage genomes, which
could have arisen by propagation in hosts with active C5-
methyltransferases. Alternatively, phages with hypermodi-
fied genomes may have a broader host range than expected.
Finally, the data may also be a hint that novel phages with
modified genomes that could be targets for TagI and other
SRA-HNH endonucleases, remain to be discovered.
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